Celon Pharma SA

Clinical trials sponsored by Celon Pharma SA, explained in plain language.

Celon Pharma SA CLN WSE

A Polish biopharmaceutical company developing drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Completed 1

New pill aims to calm schizophrenia symptoms fast

Symptom relief Completed

This study tested a new drug called CPL500036 in 189 people having a sudden worsening of schizophrenia symptoms. Participants took either a low dose, high dose, or placebo for 28 days. The main goal was to see if the drug reduces symptoms like hallucinations and delusions better …

Phase 2 • Sponsor: Celon Pharma SA • Aim: Symptom relief

Last updated Jun 26, 2026 16:11 UTC

Celon Pharma SA

New pill aims to calm schizophrenia symptoms fast